Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Find generic entry opportunities
Manage your formulary budget
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
This chart shows the companies which have received the most New Combination exclusivities in the past five years.
New Combinations are one of the categories for which the FDA grants three years of exclusivity for 'New Clinical Investigations.'
Alternate categories worth of three years of protection include identifying a New Patient Population, New Product, or New Strength.
The companies with the most New Combination drugs are: